S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
"Prepare for Five Years of Famine" (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
"Prepare for Five Years of Famine" (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
"Prepare for Five Years of Famine" (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
"Prepare for Five Years of Famine" (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Fed's Shocking New Plan to Control Your Money (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NASDAQ:SEER

Seer - SEER Stock Forecast, Price & News

$3.83
+0.07 (+1.86%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.74
$3.88
50-Day Range
$3.63
$5.51
52-Week Range
$3.59
$16.53
Volume
281,499 shs
Average Volume
462,716 shs
Market Capitalization
$244.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Seer MarketRank™ Forecast

Analyst Rating
Hold
1.67 Rating Score
Upside/​Downside
148.0% Upside
$9.50 Price Target
Short Interest
Bearish
7.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.05mentions of Seer in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$175,635 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.55) to ($1.54) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Medical Sector

528th out of 995 stocks

Analytical Instruments Industry

20th out of 28 stocks


SEER stock logo

About Seer (NASDAQ:SEER) Stock

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Receive SEER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seer and its competitors with MarketBeat's FREE daily newsletter.

SEER Stock News Headlines

Analyzing Seer (NASDAQ:SEER) & Illumina (NASDAQ:ILMN)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Seer A earnings: here's what to expect
Earnings Outlook For Seer
Modern Day Options Trading For Beginners!
These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. pixel
Q4 2022 Seer Inc Earnings Call
See More Headlines
Receive SEER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seer and its competitors with MarketBeat's FREE daily newsletter.

SEER Company Calendar

Last Earnings
11/09/2021
Today
3/28/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SEER
Fax
N/A
Employees
118
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$6.50
Forecasted Upside/Downside
+148.0%
Consensus Rating
Hold
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-92,970,000.00
Net Margins
-600.10%
Pretax Margin
-600.05%

Debt

Sales & Book Value

Annual Sales
$15.49 million
Book Value
$7.05 per share

Miscellaneous

Free Float
52,296,000
Market Cap
$244.12 million
Optionable
Not Optionable
Beta
1.27

Key Executives

  • Dr. Omid C. Farokhzad M.D.Dr. Omid C. Farokhzad M.D. (Age 53)
    Ph.D., Founder, Pres, CEO & Chair of the Board of Directors
    Comp: $944.88k
  • Mr. David R. HornMr. David R. Horn (Age 54)
    Exec. VP, Treasurer & CFO
    Comp: $552.18k
  • Ms. Elona Kogan Esq. (Age 53)
    J.D., Gen. Counsel & Sec.
    Comp: $525k
  • Mr. Joe Laws
    Chief Technology Officer and Co-Founder
  • Kenny Ross
    Chief Operations & Product Officer
  • Ms. Karen Possemato
    Chief Marketing Officer
  • Ms. Marissa Dixon
    Chief People Officer
  • Dr. Serafim Batzoglou Ph.D.
    Chief Data Officer
  • Mr. Martin Goldberg Ph.D.
    Sr. VP of Devel.
  • Mr. Scott D. Thomas (Age 49)
    Chief Commercial Officer













SEER Stock - Frequently Asked Questions

Should I buy or sell Seer stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Seer in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SEER shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SEER, but not buy additional shares or sell existing shares.
View SEER analyst ratings
or view top-rated stocks.

What is Seer's stock price forecast for 2023?

3 Wall Street analysts have issued 12 month price objectives for Seer's stock. Their SEER share price forecasts range from $6.50 to $12.00. On average, they anticipate the company's share price to reach $9.50 in the next year. This suggests a possible upside of 148.0% from the stock's current price.
View analysts price targets for SEER
or view top-rated stocks among Wall Street analysts.

How have SEER shares performed in 2023?

Seer's stock was trading at $5.80 on January 1st, 2023. Since then, SEER stock has decreased by 34.0% and is now trading at $3.83.
View the best growth stocks for 2023 here
.

When is Seer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our SEER earnings forecast
.

How were Seer's earnings last quarter?

Seer, Inc. (NASDAQ:SEER) posted its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.01. The firm had revenue of $2.16 million for the quarter, compared to the consensus estimate of $1.33 million. Seer had a negative trailing twelve-month return on equity of 19.96% and a negative net margin of 600.10%.

What ETFs hold Seer's stock?

ETFs with the largest weight of Seer (NASDAQ:SEER) stock in their portfolio include SPDR S&P Kensho New Economies Composite ETF (KOMP).Fidelity Blue Chip Growth ETF (FBCG).

What guidance has Seer issued on next quarter's earnings?

Seer updated its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $23.00 million-$25.00 million, compared to the consensus revenue estimate of $24.10 million.

When did Seer IPO?

(SEER) raised $150 million in an initial public offering on Friday, December 4th 2020. The company issued 8,800,000 shares at $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen acted as the underwriters for the IPO.

What is Seer's stock symbol?

Seer trades on the NASDAQ under the ticker symbol "SEER."

Who are Seer's major shareholders?

Seer's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (3.57%), Price T Rowe Associates Inc. MD (2.08%), Geode Capital Management LLC (1.34%), JPMorgan Chase & Co. (1.22%), 1888 Investments LLC (0.63%) and Dimensional Fund Advisors LP (0.61%). Insiders that own company stock include David R Horn, David R Horn, Elona Esq Kogan, Growth Fund Limited Part Amoon, Omead Ostadan, Omid Farokhzad, Public Equities LP Invus and Terrance Mcguire.
View institutional ownership trends
.

How do I buy shares of Seer?

Shares of SEER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Seer's stock price today?

One share of SEER stock can currently be purchased for approximately $3.83.

How much money does Seer make?

Seer (NASDAQ:SEER) has a market capitalization of $244.12 million and generates $15.49 million in revenue each year. The company earns $-92,970,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis.

How many employees does Seer have?

The company employs 118 workers across the globe.

How can I contact Seer?

The official website for the company is www.seer.bio. The company can be reached via phone at 650-453-0000 or via email at investor@seer.bio.

This page (NASDAQ:SEER) was last updated on 3/28/2023 by MarketBeat.com Staff